Bacteriophage Composition Targeting E. coli and B. fragilis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating or preventing bacterial-associated cancers are inadequate, as they often lead to the development of bacterial resistance and do not effectively target carcinogenic bacteria.
Innovation Solution
A bacteriophage composition comprising one or more bacteriophages that specifically target and lyse carcinogenic bacteria, such as E. coli and B. fragilis, is administered to patients to treat or prevent bacterial-associated cancers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibacterial agents are used to treat bacterial infections, then bacterial growth is inhibited, but bacterial resistance develops
Solution Approach 1:
The patent changes the fundamental parameter of the antimicrobial agent from chemical (antibiotics) to biological (bacteriophages). Bacteriophages are viruses that specifically infect and lyse bacteria, offering an alternative mechanism that does not rely on chemical pathways that bacteria can resist through metabolic adaptation.
Solution Approach 2:
Instead of using chemicals to kill bacteria (top-down approach), the patent employs biological agents that are specifically targeted at the bacteria (bottom-up approach). The bacteriophages naturally seek out and destroy their bacterial hosts through biological recognition and lysis, inverting the traditional chemical warfare paradigm.
2Reliability
If conventional cancer therapeutics are used to treat bacterial-associated cancers, then tumor growth is inhibited, but toxicity to healthy cells occurs
Solution Approach 1:
The bacteriophage treatment applies local quality by specifically targeting only the bacteria-infected cells through the bacteria's unique surface markers. The phages naturally home in on their bacterial hosts, delivering a localized therapeutic effect that spares healthy, non-infected cells from exposure to the therapeutic agent.
Solution Approach 2:
The bacteria themselves serve as intermediaries or carriers that direct the bacteriophage therapy to the tumor site. Since the bacteria are already localized in the tumor tissue, the phages that infect these bacteria are automatically delivered to the cancerous areas, using the bacteria as a biological guide or mediator.
3Reliability
If broad-spectrum antibacterial agents are used to eliminate carcinogenic bacteria, then bacterial diversity is reduced, but beneficial bacteria are also affected
Solution Approach 1:
The bacteriophage exhibits local quality through its highly specific host range. Each phage strain is engineered or selected to recognize and infect only specific bacterial species or strains through unique surface receptor recognition. This specificity allows selective elimination of pathogenic bacteria while leaving beneficial flora untouched, maintaining microbial ecosystem stability.
Solution Approach 2:
Instead of using broad-spectrum chemical agents that non-selectively kill bacteria, the patent inverts to a highly selective biological approach where phages naturally discriminate between different bacterial types through molecular recognition, achieving the opposite effect of broad-spectrum agents through specific targeting.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bacteriophage composition effectively lysing bacteria associated with cancers, reducing the risk of bacterial resistance and providing an alternative to conventional antibacterial agents and cancer therapeutics.
Implementation Method 1
one or more distinct bacteriophages having lytic activity against carcinogenic bacteria
Data Source
AI summary
The present invention relates to a bacteriophage composition comprising one or more (suitably two or more, or three) bacteriophages that target oncogenic (tumorigenic) bacteria, and use of the same for treating or preventing cancer.